Grace Therapeutics Inc (GRCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2025 | 03-2024 | 03-2023 | 03-2022 | 03-2021 | |
| Sales | 0 | 0 | 0 | 0 | 196 |
| Cost of Goods | N/A | N/A | N/A | N/A | 76 |
| Gross Profit | N/A | N/A | N/A | N/A | 120 |
| Operating Expenses | 16,679 | 12,852 | 52,155 | 15,589 | 16,615 |
| Operating Income | -16,679 | -12,852 | -52,155 | -15,589 | -16,419 |
| Interest Expense | 0 | 0 | 0 | 0 | 3,259 |
| Other Income | 3,912 | -1,833 | 184 | 5,122 | 0 |
| Pre-tax Income | -12,767 | -14,685 | -51,971 | -10,467 | -19,678 |
| Income Tax | -3,199 | -1,832 | -9,542 | -648 | N/A |
| Net Income Continuous | -9,568 | -12,853 | -42,429 | -9,819 | -19,678 |
| Net Income | $-9,568 | $-12,853 | $-42,429 | $-9,819 | $-19,678 |
| EPS Basic Total Ops | -0.79 | -1.35 | -5.71 | -1.62 | -7.98 |
| EPS Basic Continuous Ops | -0.79 | -1.35 | -5.71 | -1.60 | -7.96 |
| EPS Diluted Total Ops | -0.79 | -1.35 | -5.71 | -1.62 | -7.98 |
| EPS Diluted Continuous Ops | -0.79 | -1.35 | -5.71 | -1.60 | -7.96 |
| EPS Diluted Before Non-Recurring Items | -1.06 | -0.91 | -2.10 | -1.62 | -5.76 |
| EBITDA(a) | $-16,672 | $-12,841 | $-52,031 | $-15,589 | $-15,495 |